Promethazine
(Phenergan, Anergan)
|
Category:
Description:
-
Antihistamine,
antiemetic, sedative, antitussive, antivertigo agent
Indications:
-
Symptomatic
relief of various allergies, active and prophylactic treatment of
motion sickness
-
Preoperative,
postoperative, or obstetric sedation
-
Nausea/vomiting
associated with anesthesia and surgery
-
Adjunct
to analgesic for control of postoperative pain
Contraindications:
Precautions:
-
Pregnancy
category C
-
Acute
asthma, bladder neck obstruction, prostatic hypertrophy
-
Predisposition
to urinary retention, cardiovascular disease, glaucoma
-
Hepatic
function impairment, hypertension, history of peptic ulcer
-
Seizure
disorder, intestinal obstruction
Adverse
Reactions (Side Effects):
-
CNS:
anxiety, confusion, dizziness, drowsiness, EPS reactions, paradoxical
hyperexcitability, euphoria, fatigue, poor coordination
-
CV:
hypotension, palpitations, tachycardia
-
EENT:
Blurred vision, dilated pupils, dry nose, nasal stuffiness, tinnitus
-
GI:
anorexia, cholestatic jaundice, constipation, diarrhea, dry mouth
nausea, vomiting
-
GU:
amenorrhea, dysuria, galactorrhea, gynecomastia, impotence, urinary
retention
-
HEME:
agranulocytosis, hemolytic anemia, thrombocytopenia
-
METAB:
hyperprolactinemia
-
RESP:
chest tightness, increased thick secretions, wheezing
-
SKIN:
photosensitivity, rash, urticaria
|
Dosage:
Administered
orally, rectally, intramuscularly, intravenously
-
Adult:
-
Antihistimine:
-
PO/PR
12.5mg 3 times daily and 25mg at bedtime
-
IM/IV
25mg, repeated in 2 hours if necessary, convert to PO as soon
as possible
-
Antiemetic:
-
Motion
sickness:
-
Sedation:
-
Child:
-
Antihistamine:
-
Antiemetic:
-
Motion
sickness:
-
Sedation:
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|